Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering

Research output: Contribution to journalArticleResearchpeer review

Authors

  • Ana M. Muñoz-Gonzalez
  • Sara Leal-Marin
  • Dianney Clavijo-Grimaldo
  • Birgit Glasmacher

Research Organisations

External Research Organisations

  • Universidad Nacional de Colombia
  • NIFE - Lower Saxony Centre for Biomedical Engineering, Implant Research and Development
  • Grupo INPAC. Fundación Universitaria Sanitas
View graph of relations

Details

Original languageEnglish
Pages (from-to)633-641
Number of pages9
JournalInternational Journal of Artificial Organs
Volume47
Issue number8
Early online date8 Aug 2024
Publication statusPublished - Aug 2024

Abstract

Cardiovascular diseases, particularly myocardial infarction, have significant healthcare challenges due to the limited regenerative capacity of injured heart tissue. Cardiac tissue engineering (CTE) offers a promising approach to repairing myocardial damage using biomaterials that mimic the heart’s extracellular matrix. This study investigates the potential of graphene nanopowder (Gnp)-enhanced polycaprolactone (PCL) scaffolds fabricated via electrospinning to improve the properties necessary for effective cardiac repair. This work aimed to analyze scaffolds with varying graphene concentrations (0.5%, 1%, 1.5%, and 2% by weight) to determine their morphological, chemical, mechanical, and biocompatibility characteristics. The results presented that incorporating graphene improves PCL scaffolds’ mechanical properties and cellular interactions. The optimal concentration of 1% graphene significantly enhanced mechanical properties and biocompatibility, promoting cell adhesion and proliferation. These findings suggest that Gnp-enhanced PCL scaffolds at this concentration can serve as a potent substrate for CTE providing insights into designing more effective biomaterials for myocardial restoration.

Keywords

    biocompatibility, Cardiac tissue engineering (CTE), electrospinning, graphene nanoplatelets (Gnp), myocardial infarction, polycaprolactone (PCL), scaffold

ASJC Scopus subject areas

Sustainable Development Goals

Cite this

Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering. / Muñoz-Gonzalez, Ana M.; Leal-Marin, Sara; Clavijo-Grimaldo, Dianney et al.
In: International Journal of Artificial Organs, Vol. 47, No. 8, 08.2024, p. 633-641.

Research output: Contribution to journalArticleResearchpeer review

Muñoz-Gonzalez, AM, Leal-Marin, S, Clavijo-Grimaldo, D & Glasmacher, B 2024, 'Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering', International Journal of Artificial Organs, vol. 47, no. 8, pp. 633-641. https://doi.org/10.1177/03913988241266088
Muñoz-Gonzalez AM, Leal-Marin S, Clavijo-Grimaldo D, Glasmacher B. Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering. International Journal of Artificial Organs. 2024 Aug;47(8):633-641. Epub 2024 Aug 8. doi: 10.1177/03913988241266088
Muñoz-Gonzalez, Ana M. ; Leal-Marin, Sara ; Clavijo-Grimaldo, Dianney et al. / Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering. In: International Journal of Artificial Organs. 2024 ; Vol. 47, No. 8. pp. 633-641.
Download
@article{36737f803c7d4873a6c7f73465304e24,
title = "Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering",
abstract = "Cardiovascular diseases, particularly myocardial infarction, have significant healthcare challenges due to the limited regenerative capacity of injured heart tissue. Cardiac tissue engineering (CTE) offers a promising approach to repairing myocardial damage using biomaterials that mimic the heart{\textquoteright}s extracellular matrix. This study investigates the potential of graphene nanopowder (Gnp)-enhanced polycaprolactone (PCL) scaffolds fabricated via electrospinning to improve the properties necessary for effective cardiac repair. This work aimed to analyze scaffolds with varying graphene concentrations (0.5%, 1%, 1.5%, and 2% by weight) to determine their morphological, chemical, mechanical, and biocompatibility characteristics. The results presented that incorporating graphene improves PCL scaffolds{\textquoteright} mechanical properties and cellular interactions. The optimal concentration of 1% graphene significantly enhanced mechanical properties and biocompatibility, promoting cell adhesion and proliferation. These findings suggest that Gnp-enhanced PCL scaffolds at this concentration can serve as a potent substrate for CTE providing insights into designing more effective biomaterials for myocardial restoration.",
keywords = "biocompatibility, Cardiac tissue engineering (CTE), electrospinning, graphene nanoplatelets (Gnp), myocardial infarction, polycaprolactone (PCL), scaffold",
author = "Mu{\~n}oz-Gonzalez, {Ana M.} and Sara Leal-Marin and Dianney Clavijo-Grimaldo and Birgit Glasmacher",
note = "Publisher Copyright: {\textcopyright} The Author(s) 2024.",
year = "2024",
month = aug,
doi = "10.1177/03913988241266088",
language = "English",
volume = "47",
pages = "633--641",
journal = "International Journal of Artificial Organs",
issn = "0391-3988",
publisher = "Wichtig Publishing Srl",
number = "8",

}

Download

TY - JOUR

T1 - Graphene-enhanced PCL electrospun nanofiber scaffolds for cardiac tissue engineering

AU - Muñoz-Gonzalez, Ana M.

AU - Leal-Marin, Sara

AU - Clavijo-Grimaldo, Dianney

AU - Glasmacher, Birgit

N1 - Publisher Copyright: © The Author(s) 2024.

PY - 2024/8

Y1 - 2024/8

N2 - Cardiovascular diseases, particularly myocardial infarction, have significant healthcare challenges due to the limited regenerative capacity of injured heart tissue. Cardiac tissue engineering (CTE) offers a promising approach to repairing myocardial damage using biomaterials that mimic the heart’s extracellular matrix. This study investigates the potential of graphene nanopowder (Gnp)-enhanced polycaprolactone (PCL) scaffolds fabricated via electrospinning to improve the properties necessary for effective cardiac repair. This work aimed to analyze scaffolds with varying graphene concentrations (0.5%, 1%, 1.5%, and 2% by weight) to determine their morphological, chemical, mechanical, and biocompatibility characteristics. The results presented that incorporating graphene improves PCL scaffolds’ mechanical properties and cellular interactions. The optimal concentration of 1% graphene significantly enhanced mechanical properties and biocompatibility, promoting cell adhesion and proliferation. These findings suggest that Gnp-enhanced PCL scaffolds at this concentration can serve as a potent substrate for CTE providing insights into designing more effective biomaterials for myocardial restoration.

AB - Cardiovascular diseases, particularly myocardial infarction, have significant healthcare challenges due to the limited regenerative capacity of injured heart tissue. Cardiac tissue engineering (CTE) offers a promising approach to repairing myocardial damage using biomaterials that mimic the heart’s extracellular matrix. This study investigates the potential of graphene nanopowder (Gnp)-enhanced polycaprolactone (PCL) scaffolds fabricated via electrospinning to improve the properties necessary for effective cardiac repair. This work aimed to analyze scaffolds with varying graphene concentrations (0.5%, 1%, 1.5%, and 2% by weight) to determine their morphological, chemical, mechanical, and biocompatibility characteristics. The results presented that incorporating graphene improves PCL scaffolds’ mechanical properties and cellular interactions. The optimal concentration of 1% graphene significantly enhanced mechanical properties and biocompatibility, promoting cell adhesion and proliferation. These findings suggest that Gnp-enhanced PCL scaffolds at this concentration can serve as a potent substrate for CTE providing insights into designing more effective biomaterials for myocardial restoration.

KW - biocompatibility

KW - Cardiac tissue engineering (CTE)

KW - electrospinning

KW - graphene nanoplatelets (Gnp)

KW - myocardial infarction

KW - polycaprolactone (PCL)

KW - scaffold

UR - http://www.scopus.com/inward/record.url?scp=85200948804&partnerID=8YFLogxK

U2 - 10.1177/03913988241266088

DO - 10.1177/03913988241266088

M3 - Article

C2 - 39113566

AN - SCOPUS:85200948804

VL - 47

SP - 633

EP - 641

JO - International Journal of Artificial Organs

JF - International Journal of Artificial Organs

SN - 0391-3988

IS - 8

ER -